Synergic Effect of Cisplatin, Adriamycin, and Cyclophosphamide Combination Chemotherapy and Radiotherapy in Non-Small Cell Lung Cancer
作者:
Shuichi Yoneda,
Takeshi Honma,
Seiichi Yoshida,
Kyong Yob Min,
Yukio Noguchi,
Mizuyoshi Sakura,
期刊:
Oncology
(Karger Available online 1985)
卷期:
Volume 42,
issue 1
页码: 1-6
ISSN:0030-2414
年代: 1985
DOI:10.1159/000225991
出版商: S. Karger AG
关键词: Cisplatin;Adriamycin;Cyclophosphamide;Combination chemotherapy;Radiotherapy;Non-small cell lung cancer
数据来源: Karger
摘要:
61 patients with inoperable non-small cell lung cancer were treated by combination chemotherapy with cisplatin, Adriamycin and cyclophosphamide. 23 patients received radiotherapy in addition to the chemotherapy. 49 out of 55 adequately treated patients were evaluable for tumor response. Of 29 patients who received chemotherapy alone, 6 (21%) achieved partial responses. Of 20 patients who received combined chemotherapy and radiotherapy, 16 (80%) achieved complete or partial responses. The median survival time was 18 months for 22 patients treated with combined therapies.
点击下载:
PDF
(2838KB)
返 回